Advertisement

Topics

Xbrane Biopharma releases interim report for the period July to September 2017

03:00 EST 13 Nov 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Press release2017-11-13 Xbrane  Biopharma  ABs  interim report for the period July - September 2017 is now available on the Company's website, www.xbrane.com. July to September Revenue SEK -47 thousand (-) EBITDA SEK -8,1...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Xbrane Biopharma releases interim report for the period July to September 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...